The pharmacogenetic testing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Pharmacogenetic Testing Market, 2024 report by The Business Research Company
offers comprehensive insights into the current state of the market and
highlights future growth opportunities.
Market Size -
The pharmacogenetic testing market size has grown rapidly in recent years. It
will grow from $10.68 billion in 2023 to $12.37 billion in 2024 at a compound
annual growth rate (CAGR) of 15.8%. The growth in the historic period can be
attributed to increasing overall drug efficacy, increasing adoption of
personalized medicine, growing need for precision diagnosis, increasing focus
on pharmacogenetic testing, and increasing medical expenses.
The pharmacogenetic testing market size is expected to see rapid growth in the
next few years. It will grow to $22.28 billion in 2028 at a compound annual
growth rate (CAGR) of 15.9%. The growth in the forecast period can be
attributed to rising research and development associated with biotechnology and
healthcare, increasing healthcare expenditure, rising prevalence Of chronic
diseases, increased accessibility, rise of telemedicine and digital health.
Major trends in the forecast period include pharmacogenetic testing,
advancements in genomic technologies, technological advancements, advances in
companion diagnostics, and innovative diagnostic tests.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report
Scope Of Pharmacogenetic Testing Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Pharmacogenetic Testing Market Overview
Market Drivers -
The increasing demand for personalized medicine is expected to propel the
growth of the pharmacogenetic testing market going forward. Personalized
medicine, also known as precision medicine, is a medical approach that tailors
healthcare decisions and treatments to the individual characteristics of each
patient. The increasing personalized medicine is due to several factors, such
as improved treatment outcomes, a focus on prevention and early detection, and
cost-effectiveness. Pharmacogenetic testing is integral to personalized
medicine by analyzing an individual's genetic makeup to predict how they will
respond to specific medications. This enables healthcare providers to tailor
treatments based on genetic factors, optimizing drug efficacy and minimizing
adverse reactions. For instance, in February 2024, according to the
Personalized Medicine Coalition, a US-based non-profit organization, the FDA
approved 16 novel personalized therapies for patients with rare diseases in
2023, compared to six in 2022. Therefore, the increasing demand for
personalized medicine is driving the growth of the pharmacogenetic testing
market.
Market Trends -
Major companies operating in the pharmacogenetics testing market are developing
advanced pharmacogenomics testing services, such as prescription-based
pharmacogenetic testing, to gain a competitive edge in the market.
Prescription-based pharmacogenetic testing refers to genetic tests that are
specifically ordered or prescribed by healthcare providers to analyze a
patient's genetic makeup before prescribing medications. For instance, in May
2023, UCSF, a US-based healthcare company, launched its pharmacogenomics
testing service. It is designed to improve the precision of medical treatments.
UCSF's pharmacogenomics testing service helps healthcare providers tailor drug
therapies based on an individual's genetic profile, aiming to enhance drug
efficacy, minimize adverse reactions, and support personalized medicine
strategies.
The pharmacogenetic testing market covered in this report is segmented –
1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests,
Single Gene Tests
2) Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal
Supplements, Vitamins, Over-The-Counter Medications
3) Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics,
Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology,
Oncology, Other Therapeutic Areas
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order
Pharmacies, Direct-to-Customer Services
5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology
Companies, Centers And Academic Institutes, Other End Users
Get an inside scoop of the pharmacogenetic testing market, Request now for
Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp
Regional Insights -
Asia-Pacific was the largest region in the pharmacogenetic testing market in
2023 and it is expected to be the fastest-growing region in the forecast
period. The regions covered in the pharmacogenetic testing market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East, Africa.
Key Companies -
Major companies operating in the pharmacogenetic testing market are CVS Health
Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated,
Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors,
Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc.,
Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs,
Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life
Sciences, YouScript, RxGenomix LLC
Table of Contents
1. Executive Summary
2. Pharmacogenetic Testing Market Report Structure
3. Pharmacogenetic Testing Market Trends And Strategies
4. Pharmacogenetic Testing Market – Macro Economic Scenario
5. Pharmacogenetic Testing Market Size And Growth
…..
27. Pharmacogenetic Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment